| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |